Lakefront Biotherapeutics NV (LKFT) News
Track canonical SquawkNews coverage tagged to LKFT, Lakefront Biotherapeutics NV. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Lakefront Biotherapeutics NV (LKFT) Repurchases 106,060 Shares
Lakefront Biotherapeutics NV repurchased 106,060 shares between Sept 21—25, 2026, under its June 9 buyback program. It held 1,633,594 treasury shares as of Sept 25 market close.Material DetailsContext by AI AnalystThis i
EQUITY | Sep 29, 2026, 08:08 PM UTC
L
Acquisition of Own Shares
Mechelen, Belgium; 29 September 2026, 22.01 CET; regulated informationWithin the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") announc
MNA | Sep 29, 2026, 08:08 PM UTC
H
Crude Oil Gains 1%; Cintas Earnings Top Views
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Wednesday. The Dow traded down 0.52% to 51,588.15 while the NASDAQ dipped 1.10% to 26,943.90. The S&P 500 also fell, drop
LIVE | Sep 23, 2026, 06:08 PM UTC
L
Lakefront Biotherapeutics Price Target Raised to $45.00/Share From $26.00 by RBC Capital
Ratings actions from Benzinga
NEWS | Sep 23, 2026, 01:01 PM UTC
L
RBC Capital upgrades Lakefront Biotherapeutics to Outperform, sets $45 price target
RBC Capital upgraded Lakefront Biotherapeutics's stock to Outperform with a price target of $45.00.The price target implies an upside of 70.7% from the Sep 22 close of $26.36.Key takeaways from the analyst notePromising
EQUITY | Sep 23, 2026, 12:51 PM UTC
L
Lakefront Biotherapeutics repurchases 127,796 own shares under buyback
Lakefront Biotherapeutics NV says that between August 24, 2026 and August 28, 2026 it repurchased 127,796 own shares under its repurchase program announced June 9, 2026.
MNA | Sep 01, 2026, 08:08 PM UTC
M
Lakefront Biotherapeutics Receives Transparency Notification As Madison Avenue Partners Crossed Above 5% Of Voting Rights
Lakefront Biotherapeutics NV ((Euronext &, NASDAQ: LKFT ) received a transparency notification from Madison Avenue Partners. Pursuant to Belgian transparency legislation1, Lakefront received a transparency notification f
MNA | Jun 29, 2026, 08:03 PM UTC